283 related articles for article (PubMed ID: 16281303)
1. New agents with antimycobacterial activity.
Marco-Contelles J; Gómez-Sánchez E
Arch Pharm (Weinheim); 2005 Nov; 338(11):562-3. PubMed ID: 16281303
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of Mycobacterium tuberculosis, Mycobacterium bovis, and Mycobacterium avium by novel dideoxy nucleosides.
Rai D; Johar M; Srivastav NC; Manning T; Agrawal B; Kunimoto DY; Kumar R
J Med Chem; 2007 Sep; 50(19):4766-74. PubMed ID: 17696514
[TBL] [Abstract][Full Text] [Related]
3. Identification of a novel oxazolidinone (U-100480) with potent antimycobacterial activity.
Barbachyn MR; Hutchinson DK; Brickner SJ; Cynamon MH; Kilburn JO; Klemens SP; Glickman SE; Grega KC; Hendges SK; Toops DS; Ford CW; Zurenko GE
J Med Chem; 1996 Feb; 39(3):680-5. PubMed ID: 8576910
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and antimycobacterial activity of 2-substituted halogenobenzimidazoles.
Kazimierczuk Z; Andrzejewska M; Kaustova J; Klimesova V
Eur J Med Chem; 2005 Feb; 40(2):203-8. PubMed ID: 15694655
[TBL] [Abstract][Full Text] [Related]
5. Growth inhibition of Mycobacterium bovis, Mycobacterium tuberculosis and Mycobacterium avium in vitro: effect of 1-beta-D-2'-arabinofuranosyl and 1-(2'-deoxy-2'-fluoro-beta-D-2'-ribofuranosyl) pyrimidine nucleoside analogs.
Johar M; Manning T; Tse C; Desroches N; Agrawal B; Kunimoto DY; Kumar R
J Med Chem; 2007 Jul; 50(15):3696-705. PubMed ID: 17602465
[TBL] [Abstract][Full Text] [Related]
6. Quantitative structure-activity relationships for the in vitro antimycobacterial activity of pyrazinoic acid esters.
Bergmann KE; Cynamon MH; Welch JT
J Med Chem; 1996 Aug; 39(17):3394-400. PubMed ID: 8765523
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and in vitro antimycobacterial activity of 2-methoxybenzanilides and their thioxo analogues.
Kozic J; Novotná E; Volková M; Stolaříková J; Trejtnar F; Vinšová J
Eur J Med Chem; 2012 Oct; 56():387-95. PubMed ID: 22907036
[TBL] [Abstract][Full Text] [Related]
8. Design and studies of novel 5-substituted alkynylpyrimidine nucleosides as potent inhibitors of mycobacteria.
Rai D; Johar M; Manning T; Agrawal B; Kunimoto DY; Kumar R
J Med Chem; 2005 Nov; 48(22):7012-7. PubMed ID: 16250660
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, structure, and antimycobacterial activity of 6-[1(3H)-isobenzofuranylidenemethyl]purines and analogs.
Braendvang M; Bakken V; Gundersen LL
Bioorg Med Chem; 2009 Sep; 17(18):6512-6. PubMed ID: 19709890
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and antimycobacterial evaluation of substituted pyrazinecarboxamides.
Dolezal M; Cmedlova P; Palek L; Vinsova J; Kunes J; Buchta V; Jampilek J; Kralova K
Eur J Med Chem; 2008 May; 43(5):1105-13. PubMed ID: 17870211
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and antimycobacterial activities of novel 6-nitroquinolone-3-carboxylic acids.
Senthilkumar P; Dinakaran M; Yogeeswari P; Sriram D; China A; Nagaraja V
Eur J Med Chem; 2009 Jan; 44(1):345-58. PubMed ID: 18502542
[TBL] [Abstract][Full Text] [Related]
12. Antimycobacterial metabolites from Plectranthus: royleanone derivatives against Mycobacterium tuberculosis strains.
Rijo P; Simões MF; Francisco AP; Rojas R; Gilman RH; Vaisberg AJ; Rodríguez B; Moiteiro C
Chem Biodivers; 2010 Apr; 7(4):922-32. PubMed ID: 20397225
[TBL] [Abstract][Full Text] [Related]
13. 2-(2-Chloro-6-fluorophenyl)acetamides as potent thrombin inhibitors.
Lee L; Kreutter KD; Pan W; Crysler C; Spurlino J; Player MR; Tomczuk B; Lu T
Bioorg Med Chem Lett; 2007 Nov; 17(22):6266-9. PubMed ID: 17889527
[TBL] [Abstract][Full Text] [Related]
14. Assessment of antimycobacterial activity of a series of mainly marine derived natural products.
König GM; Wright AD; Franzblau SG
Planta Med; 2000 May; 66(4):337-42. PubMed ID: 10865450
[TBL] [Abstract][Full Text] [Related]
15. Fluorinated 1,2,4-Triazolo[1,5-a]pyrimidine-6-carboxylic acid derivatives as antimycobacterial agents.
Abdel-Rahman HM; El-Koussi NA; Hassan HY
Arch Pharm (Weinheim); 2009 Feb; 342(2):94-9. PubMed ID: 19173243
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and antimycobacterial evaluation of benzofurobenzopyran analogues.
Prado S; Janin YL; Saint-Joanis B; Brodin P; Michel S; Koch M; Cole ST; Tillequin F; Bost PE
Bioorg Med Chem; 2007 Mar; 15(5):2177-86. PubMed ID: 17208445
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and anti-mycobacterial evaluation of some pyrazine-2-carboxylic acid hydrazide derivatives.
Abdel-Aziz M; Abdel-Rahman HM
Eur J Med Chem; 2010 Aug; 45(8):3384-8. PubMed ID: 20488590
[TBL] [Abstract][Full Text] [Related]
18. Diversity-oriented synthesis of furo[3,2-f]chromanes with antimycobacterial activity.
Alvey L; Prado S; Saint-Joanis B; Michel S; Koch M; Cole ST; Tillequin F; Janin YL
Eur J Med Chem; 2009 Jun; 44(6):2497-505. PubMed ID: 19232450
[TBL] [Abstract][Full Text] [Related]
19. New 1,4-di-N-oxide-quinoxaline-2-ylmethylene isonicotinic acid hydrazide derivatives as anti-Mycobacterium tuberculosis agents.
Torres E; Moreno E; Ancizu S; Barea C; Galiano S; Aldana I; Monge A; Pérez-Silanes S
Bioorg Med Chem Lett; 2011 Jun; 21(12):3699-703. PubMed ID: 21570839
[TBL] [Abstract][Full Text] [Related]
20. Antimycobacterial activity: synthesis of novel 3-(substituted phenyl)-6,7-dimethoxy-3a,4-dihydro-3H-indeno[1,2-c]isoxazole analogues.
Ali MA; Ismail R; Choon TS; Pandian S; Hassan Ansari MZ
J Enzyme Inhib Med Chem; 2011 Aug; 26(4):598-602. PubMed ID: 21714764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
